UK markets open in 7 hours 24 minutes

Intrepid Potash, Inc. (IPI)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
26.49+0.18 (+0.68%)
At close: 04:00PM EDT
26.49 0.00 (0.00%)
After hours: 05:53PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close26.31
Open26.29
Bid23.44 x 800
Ask26.39 x 1300
Day's range25.68 - 26.50
52-week range17.23 - 28.30
Volume97,135
Avg. volume118,608
Market cap351.498M
Beta (5Y monthly)2.18
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date13 Dec 2012
1y target estN/A
All
News
  • GlobeNewswire

    Intrepid Announces First Quarter 2024 Results

    Denver, CO, May 08, 2024 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. ("Intrepid", the "Company", "we", "us", "our") (NYSE:IPI) today reported its results for the first quarter of 2024. Key Highlights for First Quarter 2024 Financial & Operational Total sales of $79.3 million, which compares to $86.9 million in the first quarter of 2023.Net loss of $3.1 million (or $0.24 per diluted share), which compares to net income of $4.5 million (or $0.35 per diluted share) in the first quarter of 2023.Gross

  • GlobeNewswire

    Intrepid Announces Date for First Quarter 2024 Earnings Release

    Denver, CO, April 24, 2024 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. (NYSE: IPI) plans to release its first quarter 2024 financial results on Wednesday, May 8, 2024, after the market closes. Intrepid will host a conference call on Thursday, May 9, 2024, at 12:00 p.m. Eastern Time to discuss the results and other operating and financial matters and answer investor questions. Management invites you to listen to the conference call by using the toll-free dial-in number 1 (800) 715-9871 or Internati

  • GlobeNewswire

    Intrepid Announces Medical Leave of Absence for Bob Jornayvaz; Intrepid Co-founder Hugh Harvey rejoins Board of Directors

    Denver, CO, April 17, 2024 (GLOBE NEWSWIRE) -- Intrepid Potash, Inc. ("Intrepid,” “we," or "our") (NYSE:IPI) today announced that on April 16, 2024, the Board of Directors (the “Board”) of Intrepid granted Bob Jornayvaz, Executive Chairman of the Board and Chief Executive Officer, a temporary medical leave of absence, effective immediately, as he recovers from his previously announced injury. In connection with Mr. Jornayvaz’s leave of absence, the Board has appointed Matt Preston, Intrepid’s cu